Today: 29 June 2026
Mortgage rates today sit near 6% as refi demand jumps and Rocket climbs in premarket
16 January 2026
2 mins read

Mortgage rates today sit near 6% as refi demand jumps and Rocket climbs in premarket

New York, January 16, 2026, 06:34 EST — Premarket

  • U.S. 30-year mortgage rates edged little early Friday, staying close to a three-year low following a steep fall this month.
  • Refinance and purchase demand are reacting, as the MBA reported a jump in applications last week.
  • Shares of Rocket Companies climbed in premarket action as investors weighed the implications of a lower-rate environment.

U.S. mortgage rates stayed close to three-year lows on Friday, with the 30-year fixed rate lingering near 6% in early surveys as the bond market searched for direction. Shares of Rocket Companies climbed 3.4% in premarket trading, reaching $23.44.

This shift is significant since rates hovering around 6% mark the first genuine decline many buyers have encountered since 2022, despite persistent high home prices. For lenders and housing-related stocks, even a modest fall in borrowing costs can trigger a sharp rise in refinancing activity.

The market has grown unusually sensitive to policy moves. Traders are zeroing in on mortgage-backed bonds and rate forecasts as key indicators of whether this easing will hold through the spring selling season.

Freddie Mac’s latest survey reported the average 30-year fixed mortgage rate at 6.06% for the week ending Jan. 15, down from 6.16% the previous week. The 15-year rate also dropped, settling at 5.38%. According to Freddie Mac Chief Economist Sam Khater, this marks the lowest weekly average in over three years.

Daily trackers showed a comparable figure. On Thursday, Mortgage News Daily reported the 30-year fixed rate at 6.04%, with the 10-year Treasury yield hovering around 4.17%—a key benchmark lenders often reference when pricing loans.

Policy moves sparked fresh momentum. Last week, President Donald Trump ordered the Federal Housing Finance Agency to purchase $200 billion in mortgage bonds from Fannie Mae and Freddie Mac. FHFA Director William Pulte told Reuters the plan kicked off with an initial $3 billion round. Mortgage-backed securities, which are tied to home loan pools, tend to see prices rise when bought up, pushing yields down and helping mortgage rates ease.

Borrowers are reacting swiftly. The Mortgage Bankers Association reported a 28.5% jump in mortgage applications for the week ending Jan. 9, with refinancing climbing 40% and purchase requests rising 16%. Joel Kan, MBA’s vice president and deputy chief economist, attributed the drop in mortgage rates last week to the news of increased MBS purchases.

Mortgage originators leaning on volume are seeing a favorable environment. Investors are tracking if reduced rates pull more borrowers in without squeezing lender margins, and if homebuyers respond as spring approaches.

The slide isn’t guaranteed. Mortgage rates could bounce back if Treasury yields climb on stronger inflation numbers or increased government borrowing. Rates might also rise if demand for mortgage bonds eases and spreads widen once more.

The calendar might shake up trading. U.S. stock and bond markets close Monday for Martin Luther King Jr. Day, extending the weekend and likely pushing liquidity into Tuesday.

Traders are now eyeing the Federal Reserve’s policy meeting on Jan. 27–28, searching for clues on how long the central bank intends to keep rates unchanged and how it views inflation risks that directly impact long-term yields and mortgage rates.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Soybeans Close Slightly Lower as Traders Reduce Long Positions Ahead of June Acreage Report
    June 28, 2026, 10:43 PM EDT. Soybeans ended Friday's session with minor losses, as July contracts expired and traders adjusted positions ahead of Tuesday's June Acreage report from USDA's National Agricultural Statistics Service (NASS). Speculators trimmed net long soybean positions by 16,139 contracts, mainly through exiting long positions. Cash bean prices declined 2.5 cents to $10.76 per bushel. Soymeal futures fell 40 cents, while soy oil front-month futures gained up to 49 points. Export sales remain strong, with old crop commitments matching USDA projections and new crop sales significantly higher than last year. Market watchers await NASS's report, which is expected to confirm 85.2 million acres planted this spring, potentially impacting prices and trade flows.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls
Previous Story

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls

Merck stock slips as FDA fast-track questions build and earnings near
Next Story

Merck stock slips as FDA fast-track questions build and earnings near

Go toTop